Literature DB >> 23490760

Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.

Anthony J Rissling1, Sung-Hyouk Park, Jared W Young, Michelle B Rissling, Catherine A Sugar, Joyce Sprock, Daniel J Mathias, Marlena Pela, Richard F Sharp, David L Braff, Gregory A Light.   

Abstract

BACKGROUND: Mismatch negativity (MNN) and P3a are event related potential (ERP) measures of early sensory information processing. These components are usually conceptualized as being "pre-attentive" and therefore immune to changes with variations in attentional functioning. This study aimed to determine whether manipulations of attention influence the amplitudes and latencies of MMN and P3a and, if so, the extent to which these early sensory processes govern concurrent behavioral vigilance performance in schizophrenia patients and normal subjects.
METHODS: Schizophrenia patients (SZ; n = 20) and Nonpsychiatric Control Subjects (NCS; n = 20) underwent auditory ERP testing to assess MMN and P3a across 4 EEG recording sessions in which attentional demand (low vs. high) and sensory modality of directed attention (visual vs. auditory) were experimentally varied.
RESULTS: Across conditions, SZ patients exhibited deficits in MMN and P3a amplitudes. Significant amplitude and latency modulation were observed in both SZ and NCS but there were no group-by-condition interactions. The amount of MMN amplitude attenuation from low- to high-demand tasks was significantly associated with increased vigilance performance in both SZ and NCS groups (r = -0.67 and r = -0.60). Several other robust associations were also observed among neurophysiologic, clinical and cognitive variables.
CONCLUSIONS: Attentional demand and modality of directed attention significantly influence the amplitude and latencies of "pre-attentive" ERP components in both SZ and NCS. Deficits in MMN and P3a were not "normalized" when attention was directed to the auditory stimuli in schizophrenia patients. The adaptive modulation of early sensory information processing appears to govern concurrent attentional task performance. The temporal window reflecting automatic sensory discrimination as indexed as MMN and P3a may serve as a gateway to some higher order cognitive operations necessary for psychosocial functioning. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23490760      PMCID: PMC3622836          DOI: 10.1016/j.schres.2013.01.035

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  90 in total

1.  Stability of the mismatch negativity under different stimulus and attention conditions.

Authors:  N Kathmann; T Frodl-Bauch; U Hegerl
Journal:  Clin Neurophysiol       Date:  1999-02       Impact factor: 3.708

2.  Stepping out of the spotlight: MMN attenuation as a function of distance from the attended location.

Authors:  Stephen R Arnott; Claude Alain
Journal:  Neuroreport       Date:  2002-12-03       Impact factor: 1.837

3.  Support for an association between mismatch negativity and social functioning in schizophrenia.

Authors:  Yuki Kawakubo; Kiyoto Kasai
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-04-05       Impact factor: 5.067

4.  Disentangling early sensory information processing deficits in schizophrenia.

Authors:  Anthony J Rissling; David L Braff; Neal R Swerdlow; Gerhard Hellemann; Yuri Rassovsky; Joyce Sprock; Marlena Pela; Gregory A Light
Journal:  Clin Neurophysiol       Date:  2012-05-18       Impact factor: 3.708

5.  Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia.

Authors:  Tamara Friedman; Pejman Sehatpour; Elisa Dias; Megan Perrin; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2011-12-21       Impact factor: 13.382

6.  Effects of risperidone on auditory event-related potentials in schizophrenia.

Authors:  Daniel Umbricht; Daniel Javitt; Gerald Novak; John Bates; Simcha Pollack; Jeffrey Lieberman; John Kane
Journal:  Int J Neuropsychopharmacol       Date:  1999-12       Impact factor: 5.176

7.  Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.

Authors:  D C Javitt; P Doneshka; S Grochowski; W Ritter
Journal:  Arch Gen Psychiatry       Date:  1995-07

Review 8.  Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.

Authors:  Michael F Green; Pamela D Butler; Yue Chen; Mark A Geyer; Steven Silverstein; Jonathan K Wynn; Jong H Yoon; Vance Zemon
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

9.  Reduced mismatch negativity predates the onset of psychosis.

Authors:  Madiha Shaikh; Lucia Valmaggia; Matthew R Broome; Anirban Dutt; Julia Lappin; Fern Day; James Woolley; Paul Tabraham; Muriel Walshe; Louise Johns; Paolo Fusar-Poli; Oliver Howes; Robin M Murray; Philip McGuire; Elvira Bramon
Journal:  Schizophr Res       Date:  2011-10-24       Impact factor: 4.939

10.  Substantial shared genetic influences on schizophrenia and event-related potentials.

Authors:  Mei-Hua Hall; Frühling Rijsdijk; Marco Picchioni; Katja Schulze; Ulrich Ettinger; Timothea Toulopoulou; Elvira Bramon; Robin M Murray; Pak Sham
Journal:  Am J Psychiatry       Date:  2007-05       Impact factor: 18.112

View more
  28 in total

1.  Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders.

Authors:  Gregory A Light; Risto Näätänen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-30       Impact factor: 11.205

2.  Decreased entropy modulation of EEG response to novelty and relevance in schizophrenia during a P300 task.

Authors:  Alejandro Bachiller; Alba Lubeiro; Álvaro Díez; Vanessa Suazo; Cristina Domínguez; José A Blanco; Marta Ayuso; Roberto Hornero; Jesús Poza; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-28       Impact factor: 5.270

3.  Decreased spectral entropy modulation in patients with schizophrenia during a P300 task.

Authors:  Alejandro Bachiller; Alvaro Díez; Vanessa Suazo; Cristina Domínguez; Marta Ayuso; Roberto Hornero; Jesús Poza; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-05       Impact factor: 5.270

4.  Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Curr Top Behav Neurosci       Date:  2014

5.  A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients.

Authors:  Caitlin K Monaghan; Sophie Brickman; Polly Huynh; Dost Öngür; Mei-Hua Hall
Journal:  Int J Psychophysiol       Date:  2019-05-17       Impact factor: 2.997

Review 6.  Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Ann N Y Acad Sci       Date:  2015-03-09       Impact factor: 5.691

7.  Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.

Authors:  Veronica B Perez; Melissa Tarasenko; Makoto Miyakoshi; Sean T Pianka; Scott D Makeig; David L Braff; Neal R Swerdlow; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2017-01-31       Impact factor: 7.853

8.  Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Authors:  Gregory A Light; Neal R Swerdlow; Michael L Thomas; Monica E Calkins; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Marlena Pela; Allen D Radant; Larry J Seidman; Richard F Sharp; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; David L Braff; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2014-10-23       Impact factor: 4.939

9.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

10.  Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm.

Authors:  Amanda McCleery; Daniel H Mathalon; Jonathan K Wynn; Brian J Roach; Gerhard S Hellemann; Stephen R Marder; Michael F Green
Journal:  Psychol Med       Date:  2019-01-15       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.